Neopterin: A Promising Candidate Biomarker for Severe COVID-19

Wasihun Hailemichael,1 Mulugeta Kiros,2 Yibeltal Akelew,3 Sisay Getu,4 Henok Andualem1 1Immunology and Molecular Biology, Medical Laboratory Science, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; 2Medical Microbiology, Medical Laboratory Science, College of Health Scienc...

Full description

Saved in:
Bibliographic Details
Main Authors: Hailemichael W (Author), Kiros M (Author), Akelew Y (Author), Getu S (Author), Andualem H (Author)
Format: Book
Published: Dove Medical Press, 2021-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c6e1a711221f4865af1cd74103f9b59d
042 |a dc 
100 1 0 |a Hailemichael W  |e author 
700 1 0 |a Kiros M  |e author 
700 1 0 |a Akelew Y  |e author 
700 1 0 |a Getu S  |e author 
700 1 0 |a Andualem H  |e author 
245 0 0 |a Neopterin: A Promising Candidate Biomarker for Severe COVID-19 
260 |b Dove Medical Press,   |c 2021-02-01T00:00:00Z. 
500 |a 1178-7031 
520 |a Wasihun Hailemichael,1 Mulugeta Kiros,2 Yibeltal Akelew,3 Sisay Getu,4 Henok Andualem1 1Immunology and Molecular Biology, Medical Laboratory Science, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; 2Medical Microbiology, Medical Laboratory Science, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; 3Immunology and Molecular Biology, Medical Laboratory Sciences, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia; 4Hematology and Immuno-Hematology, Medical Laboratory Science, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaCorrespondence: Wasihun HailemichaelImmunology and Molecular Biology, Medical Laboratory Science, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaTel +251 946111414Email wasihunh383@gmail.comAbstract: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has rapidly spread across the world since its first emergence in China in late 2019. It is a major public health concern with no effective treatct 3ments. The immunopathology of SARS-CoV-2 is associated with an excessive inflammatory response. Macrophage activation syndrome (MAS) is also associated with the severity of the disease in SARS-CoV-2-infected patients. Neopterin is a macrophage activation marker produced by monocytes and macrophages upon activation by interferon-gamma (IFN-γ). Neopterin is a well-established marker in a variety of diseases, and recent evidence indicates that it could be helpful in early prediction of the severity of COVID-19 disease and serve as a prognostic marker. Here, we outline the role of macrophage activation syndrome in the pathogenesis of SARS-CoV-2 and suggest that neopterin could be used as a biomarker for progression of COVID-19.Keywords: neopterin, biomarker, MAS, SARS-CoV-2, COVID-19 
546 |a EN 
690 |a neopterin 
690 |a biomarker 
690 |a mas 
690 |a sars-cov-2 
690 |a covid-19 
690 |a Pathology 
690 |a RB1-214 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Inflammation Research, Vol Volume 14, Pp 245-251 (2021) 
787 0 |n https://www.dovepress.com/neopterin-a-promising-candidate-biomarker-for-severe-covid-19-peer-reviewed-article-JIR 
787 0 |n https://doaj.org/toc/1178-7031 
856 4 1 |u https://doaj.org/article/c6e1a711221f4865af1cd74103f9b59d  |z Connect to this object online.